key: cord-1029210-p58ff5mr authors: Gianotti, Raffaele; Restano, Lucia; Cutrone, Mario; Colonna, Cristiana; Fellegara, Giovanni; Debernardi, Isacco; Boggio, Francesca; Del Gobbo, Alessandro; Monzani, Nicola Adriano; Tripodo, Claudio; Gelmetti, Carlo; Berti, Emilio title: Papulo‐purpuric dermatitis of childhood: a distinct PLEVA‐like eruption associated to SARS‐CoV‐2 infection. Clinical, histopathological and immunohistochemical study of 10 cases date: 2021-08-31 journal: Pediatr Dermatol DOI: 10.1111/pde.14777 sha: d78a7468c9efd7591b3134354023bfbe88bf95fa doc_id: 1029210 cord_uid: p58ff5mr We observed ten children with a papular eruption with purpuric features during the SARS‐CoV‐2 pandemic in Northern Italy (May‐December 2020). Histological examination showed signs of SARS‐CoV‐2‐related dermatosis. Evidence of nucleocapsid viral proteins using SARS‐CoV‐2 (2019‐nCoV) nucleocapsid antibody revealed cuticular staining of the deep portion of the eccrine glands in all cases. Mild systemic symptoms were present in 6 out of 10 patients and were characterized by fever (five cases), asthenia (two cases), joint pain (one case), headache (one), and cough (one). These were present a few days before and during early skin eruption, with an average duration time of 13 days (range 5-20 days), subsiding with either no therapy or a short course of NSAIDs. Skin lesions spontaneously resolved without treatment, with a mean time of 8.8 weeks (range 4.0-12.0 weeks), leaving hypochromic lenticular lesions in five cases accompanied by atrophy and telangiectasias in two patients ( All the skin biopsies were characterized by dermal lymphocytic infiltrate. In five cases (N 3,4,5,8, and 10), histopathology revealed a diffuse interface dermatitis, consisting of CD4+ and CD8+ lymphocytes that diffusely infiltrated the epithelium inducing scattered necrosis of keratinocytes. Lymphocyte cuffs were particularly evident surrounding the acrosyringeal ducts, dermal eccrine ducts, and deep eccrine glands. In addition to these features, one case (N5) also showed diffuse thrombosis of the superficial dermal small vessels in absence of leukocytoclastic vasculitis. (Figure 4 ). In the remaining three cases (N 2,7, and 9), the fully developed lesion had a dense coat or sleeve-like perivascular lymphoid infiltrate and many interstitial eosinophils. Capillaries were conspicuously dilated and engorged with red blood cells. Extravasated erythrocytes were frequently observed in papillary dermis. A massive lymphoid infiltration was present surrounding dermal ducts and deep eccrine glands. (Figure 5 ). immunohistochemical staining was limited to the cuticular region of the eccrine glands; however, in one case it was also present at the acrosyringium. As a reliability check of the monoclonal antibody, we used five pediatric cases of PLEVA (year 2018) as negative control. No immunohistochemical staining was detected in all control cases. All cases reported herein showed clear and strong cuticular staining of the deep portion of the eccrine glands ( Figure 6 ). The morphology, distribution, and sudden onset of multiple subsequent lesions were very similar to those observed in PLEVA, a condition that also has been viewed as an altered immune response to a viral antigenic trigger. 5 However, our cases were distinct due to the intensely red-purple color of the lesions as opposed to the red-brown color of acute pytiriasis lichenoides and the evident prevalence of the purpuric component seen with dermoscopy; moreover, in our cases even smaller lesions tended to develop early hemorrhagic crusts rather than resolve with desquamation. Laboratory testing ruled out coagulation disorders, vasculitis, and other known infectious causes of papulo-purpuric eruptions. 5 In all cases, histopathological examination showed highly suspected clues for COVID-19 related dermatosis. 6, 7 Features observed in patients N 3,4,5,8, and 10 could be histologically classified as PLEVA due to band-like infiltration with scattered necrotic keratinocytes and diffuse lymphocytes exocytosis. However, the massive infiltration of acrosyringeal and the dense deep periglandular lymphocytic infiltration are not a typical feature of Mucha-Habermann disease, but have been consistently described in COVID-19-related dermatosis. 6, 7 The histological features observed in patients N 2,7, and 9 that may represent a different stage of the same spectrum also do not fit completely with the standard histopathological description of PLEVA. Superficial and deep perivascular dermatitis with perivascular, periductal, and periglandular lymphocytic sleeves associated with focal blood extravasation has not been frequently described in inflammatory skin diseases prior to SARS-CoV-2 infection. 6 A case with the same histopathological and immunological features in which mRNA-FISH detected the spike glycoprotein of SARS-CoV-2 in eccrine glands, however, was recently described in a young woman. 8 The immunohistochemical positivity in eccrine glands has already been described by several authors 9,10 and our findings confirm that this epithelial component could also play a role in modulating the autoimmune cross-reactivity, maybe also leading to IL-1, IFNγ, and TNFα release and recruiting cytotoxic and NK cells that target the keratinocytes, as has been already shown in HSV related to erythema multiforme. 11 The peculiar clinical and histopathological aspect of the lesions in our patients and the number and frequency of cases, over a relatively short pandemic period, pointed to an association with SARS-CoV-2 as etiologic agent. Furthermore, as already stated, PLEVA eruptions has been already described as paraviral exanthema, 5 making our assumption reasonable also since it was supported by the immunohistochemical analysis performed. A positive result with throat swab or serology for SARS-CoV-2, however, was obtained only in four out of ten patients. Findings of nucleocapsid viral proteins using the SARS-CoV-2 antibody through immunohistochemical analysis still needs to be largely validated in the skin, but seems to be promising to detect SARS-CoV-2 in COVID-19-related dermatosis, especially in pauci-symptomatic children and young adults with PCR swab negativity. 12, 13 In infancy and young adulthood, it was hypothesized that a high type I interferon response, crucial in the early response to viral infections, might explain the relatively low rate of seropositivity in patients with chilblains because such patients could clear SARS-CoV-2 infection before humoral immunity can occur. 2,3 A similar mechanism may have occurred in our cases. All these facts lead us to believe that these distinctive clinicpathological pediatric features could represent a peculiar COVID-19 associated dermatosis of childhood. Our study, however, exhibits limitation such as the unavailability of confirmation of SARS-CoV-2 infection performed with other methods and the low number of cases presented, and further observation is needed to confirm and validate our hypothesis. In memory of Professor Raffaele Gianotti, dermatopathologist, passed away on March 2021. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblainlike lesions during the COVID-19 pandemic Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases Similarities in cutaneous histopathological patterns between COVID-19-positive and COVID-19 high-risk patients with skin dermatosis Histopathological study of a broad spectrum of skin dermatoses in patients affected or highly suspected of infection by COVID-19 in the northern part of italy: analysis of the many faces of the viral-induced skin diseases in previous and new reported cases COVID-19-related dermatosis in November 2019: could this case be Italy's patient zero? Infection of human sweat glands by SARS-CoV-2 COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient From HSV infection to erythema multiforme through autoimmune crossreactivity Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing Chilblain-like lesions in children following suspected COVID-19 infection Papulo-purpuric dermatitis of childhood: a distinct PLEVA-like eruption associated to SARS-CoV-2 infection Clinical, histopathological and immunohistochemical study of 10 cases No conflicts of interest to declare. data available upon request to the corresponding author. https://orcid.org/0000-0002-5569-8237Nicola Adriano Monzani https://orcid. org/0000-0001-7332-3888